Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: J Allergy Clin Immunol. 2012 Jan 10;129(3):687–693.e1. doi: 10.1016/j.jaci.2011.12.001

Figure 3. Changes in the expression of steroid regulated targets in PBMC from SR and SS asthmatics after in vitro treatment with DEX prior to (Visit 1), and 30 days post prednisone burst (Visit 3).

Figure 3

Significantly reduced suppression of TNF-alpha (panel A) and IL-8 (panel B) mRNA by DEX is observed in PBMC from SR asthmatics than SS asthmatics, as detected by real time PCR at Visit 1, but not Visit 3 (the difference between SR and SS asthma groups was analyzed by unpaired t-test).